Dr. Myrlene Staten
DIVISION OF DIABETES, ENDOCRINOLOGY, & METABOLIC DISEASES
NIDDK, National Institutes of Health
Building 2DEM, Room 6107
6707 Democracy Blvd.
Bethesda, MD 20817
Senior Advisor, Diabetes Translational Research
Manage a portfolio of clinical translation and clinical treatment grants for type 2 diabetes.
Run the Type 1 Diabetes – Rapid Access to Intervention Development preclinical drug development program.
Program official for the TINSAL-T2D study, an efficacy study of salsalate in
type 2 diabetes.
Participate in other large, NIDDK clinical studies including HEALTHY and Longitudinal
Assessment of Bariatric Surgery.
Lead the Clinical Team within DEM
Previous Training and Experience:
B.S. in Nutrition, Summa Cum Laude, Texas Christian University, Fort Worth, TX
M.D., Graduation with High Honors, University of Texas Medical Branch,
Galveston, TX (1976‑1979)
Internship and Residency in Medicine, University of California at Irvine Medical Center,
Orange, CA (1979-1982)
Fellowship in Endocrinology and Metabolism, Washington University School
of Medicine, St. Louis, MO (1982-1985)
Instructor, Assistant Professor, Department of Internal Medicine, Washington University
School of Medicine (1985-1989)
Various clinical research positions with major pharmaceutical companies (1989-1999)
including Amgen, Bristol-Myers Squibb and Hoffman-LaRoche
Vice President-CV/Endocrine/Metabolic Diseases Clinical Research, Pharmacia,
Peapack, NJ (1999-2003)
Board certified in Internal Medicine and Endocrinology and Metabolism
Committees/ Working Groups:
NIDDK Bench to Bedside Translation Working Group (Chair)
The Biomarkers Consortium for the Foundation for the National Institutes of Health
NIDDK representative the NIH pilot RAID program (lead a subcommittee on IC
Coordination and Outreach and participate in the NIH-RAID Evaluation and Planning
Type 2 diabetes planning group (Chair)
NIDDK Obesity Working Group
NIDDK Diabetes Complications Working Group
ADA Insulin Standardization Working Group
Page last updated: January 01, 0001